Advertisement CardioNet prices public offer at $18 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

CardioNet prices public offer at $18

CardioNet has announced the initial public offering of 4.5 million shares of common stock at a price of $18 per share. Three million shares are being offered by CardioNet and 1.5 million shares are being offered by Guidant Investment.

In addition, Guidant Investment has granted to the underwriters a 30-day option to purchase up to an additional 675,000 shares of common stock to cover over-allotments, if any.

The offering is being made through an underwriting syndicate led by Citigroup Global Markets, acting as the sole book-running manager. Lehman Brothers is acting as joint lead manager and Leerink Swann and Thomas Weisel Partners are acting as co-managers.